Health ❯ Healthcare ❯ Medical Treatments

Oncology

Lung Cancer Multiple Myeloma Glioma Bladder Cancer Melanoma Therapy Chronic Myeloid Leukemia Small Cell Lung Cancer Breast Cancer Desmoid Tumors Chemotherapy Acute Myeloid Leukemia Brain Tumors Hodgkin Lymphoma Colorectal Cancer Prostate Cancer Melanoma Immunotherapy CAR T-cell Therapy Non-Small Cell Lung Cancer

FDA Approves Nivolumab Plus AVD as First-Line Therapy for Advanced Hodgkin Lymphoma

The decision follows a head-to-head phase 3 trial that showed a marked progression-free survival advantage over brentuximab vedotin plus AVD.

FDA Clears Enhertu-Perjeta Combo for First-Line HER2-Positive Metastatic Breast Cancer

FDA Approves Perioperative Keytruda–Padcev for Cisplatin‑Ineligible Muscle‑Invasive Bladder Cancer

FDA Approves Darzalex Faspro as First Therapy for High-Risk Smoldering Multiple Myeloma

FDA Approves Lurbinectedin Plus Atezolizumab for First-Line Maintenance in Extensive-Stage SCLC

European Commission Approves Voranigo for IDH-Mutant Grade 2 Glioma